Next Article in Journal
Neuroprotective Effects of α-Tocotrienol on Kainic Acid-Induced Neurotoxicity in Organotypic Hippocampal Slice Cultures
Next Article in Special Issue
Noncoding RNA in Oncogenesis: A New Era of Identifying Key Players
Previous Article in Journal
Self-Organizing Cyclolinear Organosilicon Polymers in Bulk and on the Surface of Water
Previous Article in Special Issue
Emerging Roles of Small Epstein-Barr Virus Derived Non-Coding RNAs in Epithelial Malignancy
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(9), 18239-18255;

Bicistronic Gene Transfer Tools for Delivery of miRNAs and Protein Coding Sequences

Department of Biological Sciences, Purdue University, 915 W State St, West Lafayette, IN 47907-1392, USA
Purdue University Center for Cancer Research, Purdue University, 201 S University Dr, West Lafayette, IN 47907-2064, USA
Author to whom correspondence should be addressed.
Received: 22 July 2013 / Revised: 8 August 2013 / Accepted: 13 August 2013 / Published: 5 September 2013
(This article belongs to the Special Issue Regulation by non-coding RNAs 2013)
Full-Text   |   PDF [2746 KB, uploaded 19 June 2014]


MicroRNAs (miRNAs) are a category of small RNAs that modulate levels of proteins via post-transcriptional inhibition. Currently, a standard strategy to overexpress miRNAs is as mature miRNA duplexes, although this method is cumbersome if multiple miRNAs need to be delivered. Many of these miRNAs are found within introns and processed through the RNA polymerase II pathway. We have designed a vector to exploit this naturally-occurring intronic pathway to deliver the three members of the sensory-specific miR-183 family from an artificial intron. In one version of the vector, the downstream exon encodes the reporter (GFP) while another version encodes a fusion protein created between the transcription factor Atoh1 and the hemaglutinin epitope, to distinguish it from endogenous Atoh1. In vitro analysis shows that the miRNAs contained within the artificial intron are processed and bind to their targets with specificity. The genes downstream are successfully translated into protein and identifiable through immunofluorescence. More importantly, Atoh1 is proven functional through in vitro assays. These results suggest that this cassette allows expression of miRNAs and proteins simultaneously, which provides the opportunity for joint delivery of specific translational repressors (miRNA) and possibly transcriptional activators (transcription factors). This ability is attractive for future gene therapy use. View Full-Text
Keywords: miRNAs; gene therapy; miR-183 family miRNAs; gene therapy; miR-183 family
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Stoller, M.L.; Chang, H.C.; Fekete, D.M. Bicistronic Gene Transfer Tools for Delivery of miRNAs and Protein Coding Sequences. Int. J. Mol. Sci. 2013, 14, 18239-18255.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top